Healthcare Innovations Boost Medical Packaging Films Industry

According to the latest market research study published by P&S Intelligence, the global medical packaging films market was valued at $7,904.2 million in 2023 and is projected to reach $11,752.8 million by 2030, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.

This growth is primarily driven by the increasing demand for medical products and equipment, attributed to a rising number of patients and an aging global population. Advancements in packaging solutions that ensure product protection further bolster the market. Medical packaging films are favored for their high transparency, chemical inertness, and lightweight properties, making them ideal for applications such as blister packs, medical bags, sachets, wraps, pouches, and labels.  

Key Insights

Material Preferences

Polyethylene (PE) is the most widely used material in medical packaging films due to its flexibility, durability, and cost-effectiveness. Polypropylene (PP) and polyvinyl chloride (PVC) also hold significant market shares, each offering unique properties suitable for specific medical packaging needs.​

Film Types

Thermoformable films dominate the market, attributed to their adaptability in forming various shapes, essential for packaging diverse medical devices and products. High-barrier films are also in demand for their superior protective qualities against moisture, oxygen, and other contaminants.

Primary Applications

Bags and pouches represent the largest application segment, owing to their versatility in storing a wide range of medical items, from liquids to instruments. Tubes and sachets follow, catering to specific packaging requirements in the medical field.

End Users

Pharmaceutical companies are the leading consumers of medical packaging films, driven by the need for safe and effective packaging for drugs and vaccines. Medical device companies also contribute significantly to market demand, ensuring the sterility and integrity of their products through specialized packaging.​

Regional Dynamics

North America holds a substantial market share, supported by advanced healthcare infrastructure and significant healthcare expenditure. The Asia-Pacific region is anticipated to witness the fastest growth, propelled by increasing healthcare investments, a burgeoning pharmaceutical sector, and a large patient population.​

Technological Advancements

Innovations in film materials, such as the development of biodegradable and recyclable options, are gaining traction. These advancements address environmental concerns and align with global sustainability initiatives, potentially reshaping the market landscape.​

Competitive Landscape

The market is characterized by the presence of key players focusing on product innovation, strategic partnerships, and mergers and acquisitions to strengthen their market position. Emerging companies are also entering the market, introducing niche products and targeting specific applications to capture market share.​

Opportunities

The growing emphasis on infection control and the increasing prevalence of chronic diseases present significant opportunities for market expansion. Additionally, the shift toward home healthcare and personalized medicine necessitates specialized packaging solutions, offering avenues for product diversification.​

The medical packaging films market is poised for substantial growth, driven by technological advancements, evolving healthcare needs, and a focus on sustainability. Stakeholders are encouraged to capitalize on emerging opportunities and address challenges to maintain a competitive edge in this dynamic market.

Read More

Pharmaceutical Sterility Testing - Industry Development and Forecast Report, 2030

In 2023, the global pharmaceutical sterility testing market revenue is estimated to rise to USD 1,769.0 million and grow at an 11.5% compound annual growth rate between 2024 and 2030, reaching a value of USD 3,763.0 million by 2030.

This development of the market can be credited to the enlargement of pharmaceutical and biotechnological companies, the surge in their R&D activities, the rise in the occurrence of diseases, and significant government investments in the healthcare industry.

The frequency of hematological malignancies is on the surge. As per The Leukemia & Lymphoma Society, every 3 minutes, an individual is diagnosed with lymphoma, myeloma, and leukemia in the U.S. Biopharmaceuticals, like gene, immune, and cell therapies, are quickly being accepted as an alternate treatment for hematological cancers. This is mainly because these therapeutics show high potency and efficiency against these diseases.

In 2023, the North American region dominated the market, with a revenue share of 55%. This can be credited to the existence of key pharmaceutical and bio-pharmaceutical companies, growing R&D activities in the biotechnology and pharmaceutical industries, an increasing number of product introductions, the high occurrence of chronic illnesses, and helpful government rules for the setup of research and development facilities in the continent. 

Furthermore, the existence of strong healthcare guidelines, strict drug approval needs, increasing public awareness of drug safety, improving acceptance of cutting-edge tech, and the launch of gene and cell therapies for the cure of various hematologic malignancies are causing the enlargement of the regional industry.

Read More

How Does Biological Molecule Analysis Boost Detectable Sensitivity of Magnetic Beads?

In 2021, the magnetic beads market was worth around USD 2,835.1 million, and it is projected to advance at a 12.2% CAGR from 2021 to 2030, hitting USD 8,012.0 million in 2030, according to P&S Intelligence.

To learn more about this report: https://bit.ly/434VKnb

In 2021, in the European industry, France generated the highest revenue. This can be credited to the rising use of magnetic beads in in-vitro diagnostics, wherein lies a requirement for cell separation, elimination of tumor cells, and hereditary analysis of precise nuclei acid sequences RNA or DNA.

The In-vitro diagnostics category is leading the magnetic beads market and will grow with a CAGR of 12.6% in the coming few years. This will mainly be because of the increasing size of in-vitro diagnostic studies to spot diseases and screen patients’ responses to medications.

This method is also utilized in precision drugs to detect patients who will be helped by the exact therapies. A key in-vitro diagnostic method that uses such beads is next-generation sequencing, which is utilized to examine an individual’s DNA to spot genomic disparities.

The APAC region is projected to experience the fastest development, with a 12.5% CAGR, in the coming few years, because of the increasing occurrence of chronic diseases in the APAC, which is eventually boosting the acceptance of pioneering diagnostic and treatment methods. Furthermore, because of the region's thriving healthcare market, the need for magnetic beads is projected to raise significantly in the future.

As Asia-Pacific is home to more than half of the world’s population, it has an enormous burden of chronic illnesses, including cancer and diabetes which are required to be cured or managed appropriately. The use of magnetic beads in ribonucleic acid extraction supports spotting tumors. Furthermore, dividing RNA is a fundamental method for replicating, stem cell research, and the study of evolutionary procedures.

Magnetic beads are also utilized in an extensive range of biomedical applications, such as nucleic acid purification, drug-targeting cell isolation, and detection. Moreover, the utilization of hard-phase magnetic beads for the identification and separation of biomolecules is a present market trend that helps in the expansion of industry in the APAC region.

With over 47% market share, North America is the biggest magnetic beads industry. The need for such agents is increasing because of the research initiatives by key players for efficient chronic disease treatment and discovery. Furthermore, the U.S. is the bigger utilizer of such items in North America due to their rising effectiveness in drug delivery, magnetic resonance imaging, tumor targeting, and several other vital clinical applications.

Hence, the magnetic beads market is developing due to the increasing requirement for these agents in in-vitro diagnosis, and such factors will also derive the industry in the future.

Read More

Ventilator Industry IS Dominated by the Adults Category

The ventilator market will grow at a rate of 7.1% in the years to come, to touch USD 2,887.32 million by 2030. This growth has a lot to do with the increasing cases of chronic diseases, such as COPD and asthma globally.

Download report sample at: https://bit.ly/3B8s9wJ

Critical care dominated the industry. This is because of the COVID-19 virus, which has affected a lot of global population. This results in the enormous necessity for critical care, because of a lot of hospitalizations.

Smoking is one of the key reasons of COPD. There are a lot of tobacco users in the low or middle-income nations. As per the CDC, cigarette smoking is a major cause of ailment, debility, and death in the U.S., and it causes for over 480,000 fatalities every year. 

North America dominated the market with over 30% share, in 2021. This is because of the increasing prevalence of respiratory ailments like bronchitis and asthma. 

COPD is perhaps the biggest threat for the people of this region. Likewise, as a result of the advanced healthcare infra in Canada and the U.S., improved ventilator systems are used more often in the region. For example, as per data made available, there were 77,000 ventilators in the hospitals of the country hospitals as of March 2020 and over 8,000 ventilators in the nursing homes of America.

It is due to the increasing count of hospital beds, the demand for ventilators will increase even further by the end of this decade.

Read More

Outsourcing Clinical Trials: Balancing Oversight and Expectations

The revenue generated by clinical trials outsourcing industry was USD 40,428.4 million in 2021, and it will power at a rate of 7.2% in the years to come, to touch USD 75,573.4 million by 2030.

Get the sample pages of this report: https://bit.ly/3nE3ixn

In the recent past, phase 3 clinical trials dominated the industry with over 36% share. Because of an enormous clinical trial in the phase 3 stage and the increased possibilities of failure in clearing this phase, pharma companies look forward to an association with outsourcing partners, which will contribute to the expansion of the industry.

Also, the phase 3 category will grow considerably in the future because it offers info on potential drug interactions along with drug safety and efficiency. Phase 3 clinical research allows medical pros and researchers a deeper understanding of drugs and side effects associated with them.

The main trend in the industry is the considerable investments that pharma companies are making for AI to restock their dissimilar pipelines. The industry is also driven by the snowballing public and private initiatives for encouraging the application of AI-powered solutions in novel medication efficacy trials, for hastening drug discovery.

The small & mid-sized companies will grow faster. Contract outsourcing transfers the implementation of drug safety functions and procedures to a third party. A number of companies outsource for reducing high preliminary investments and fixed costs, advance resource flexibility, and safe additional capacity.

North America was the largest contributor in the past, as per P&S intelligence. This is because of the existence of developed healthcare infra, high healthcare spending, the rise in progressive drug research studies, high spending in clinical trials, and the existence of important players.

APAC will experience the fastest growth, advancing at a rate of over 7.5%, in the years to come. This has a lot to do with the improving healthcare infra, growing drug research activities, and increasing incidence of diseases.

It is because of the growing production of new pharmaceuticals, the demand for clinical trials outsourcing will continue to rise in the coming years as well.

Read More

How Does Ultrasound Device Improve Healthcare?

The total size of the ultrasound devices market was at USD 6,929.7 million in 2021, and it will grow at a rate of 6.4% by the end of this decade, to reach USD 12,073.4 million by 2030.

Get the sample pages of this report: https://bit.ly/3FZyjlV

The medical device tech is transitioning in the direction of miniaturization, with transportable, lightweight devices substituting their bulky counterparts. For providing point-of-care treatment to patients, healthcare institutions are laying much emphasis on the employment of lightweight and compact devices.

Due to this, manufacturers in are introducing portable devices for facilitating improved healthcare.

Hence, the diminishment of ultrasound devices has brought about increased use in emergency and ICUs. 

Handheld devices come good for physicians in routine bedside scanning, which additionally decreases the overall cost and time related with healthcare. 

Used in deep therapy. So, compact/handheld portable ultrasound devices had a major share.

The ageing population necessitates wide-ranging care as it is susceptible to to illnesses as a result of its low levels of immunity, with the long recovery time additionally degrading its life quality. 

Diseases like diabetes and cardiac disorders are extremely prevalent in elder people as a result of their weak regenerative abilities, therefore leading to a surge in the requirement for improved diagnosis and therapy.

Ultrasonic imaging is a prevailing diagnostic tool for medical practitioners and researchers, and it is extensively acknowledged by reason of its non-invasive nature. Furthermore, the tech progressions in computing applications and transducers have transformed them and prolonged their application. 

Furthermore, device display is divided into B/W, color ultrasound of which the demand for color variants will grow with a rate of about 7% in the years to come.

In the recent past, the general imaging category dominated the ultrasound devices market with about 40%, as stated by a market research company, P&S Intelligence. 

This is as a result of the increasing obtainability of HIFU and the preference for them amongst physicians throughout tissue biopsy and the cancer treatment and  a number of other diseases.

Furthermore, end users demand for these kinds of devices is the highest amongst surgical centers, hospitals,  and diagnostics centers. This can be credited to the easy obtainability of sonography-based medical processes at these medical centers, development in in key regions, and increase in the usage of MIS diagnostic and surgical procedures here.

Europe had the most sales revenue, about 40%, in in the recent past. The development in focused ultrasound's clinical uses and the early commercialization of these devices, along with the considerable healthcare outlay across the advanced European nations, are helping the industry to grow.

It is because of the increasing elderly population across the world, the demand for ultrasound devices is on the rise, in the years to come.

Read More

Hospital Beds: Types and Importance

A bed is more than just an area to sleep in at a hospital. This is a piece of medical gear that has been carefully selected to fit the patient's unique demands. The ability to position patients on hospital beds for optimum comfort and recovery makes them vital.

Additionally, a variety of hospital beds with cutting-edge features are offered on the marketplace, including beds with hydraulic adjustment and beds powered by alternating current (AC) to change the surface and height level of the bed. These factors will cause the hospital bed market to reach $8,276.7 million in 2030.

To learn more about this report: https://bit.ly/40xSeQJ

Why Do Hospital Beds Matter So Much?

Hospital beds are crucial for a variety of reasons. Patients may relax and recover in a welcoming and secure environment thanks to them. Additionally, hospital beds make it simple to reach medical personnel and equipment. 

In an emergency, this may be very important. Additionally, hospital beds may be altered to accommodate certain patients' needs, which is crucial for people with mobility concerns.

Due to the patient's comfort and convenience of changing positions, a hospital bed with an electric motor is a great option. One of a hospital bed's most crucial components, safety rails are meant to lessen the likelihood of the most frequent accidents.

Everyone concerned will heal much more easily and quickly if the proper hospital bed is used. By using an automatic hospital bed, the patient is protected from the discomforts associated with sitting in a wheelchair as well as the signs of spine misalignment.

Improvements in Hospital Bed Technology

A number of technical developments, like the availability of autonomous beds and hospital beds with IoT capabilities, are promoting the expansion of the hospital bed sector. 

Hospital beds equipped with power mattresses, which aid in pressure redistribution and enhance blood circulation in bedridden patients, have also been developed by major corporations.

Moreover, old beds are also being replaced by beds with new & advanced features, such as graphical interfaces, novel environment-aware sensors, and actuating solutions.

Types of Hospital Bed 

Patients may customize any modern hospital bed to suit their changing demands since they are all adaptable. What powers the various kinds of hospital beds is what distinguishes them. Hospital beds come in three different varieties: semi-electric, manual, and completely electric.

Manual: The height of these beds may be changed, and the foot and head of the bed can be raised and lowered using hand cranks. The capacity to use this type of bed and, consequently, the patient's comfort and freedom, should be physically possible for the patient or caregiver.  

Semi-Electric: The bed's head and foot rails are lowered and raised by an electric motor. The patient physically turns a hand crank to change the height of the bed.

Fully Electric: With the use of a pendant or remote, the patient may adjust the position and height of the bed. The bed may be raised to a suitable height without the need for a hand crank, making it simpler to get in and out of bed and for the caregiver to tend to the sufferer or change their bedding.

Read More

North America Leads the Way for ENT Devices Industry

The ENT devices market was valued $17,440 million in 2021, and will reach $31,805 million by 2030, at a growth rate of 7% in the years to come. The thriving incidence of hearing ailments and sinusitis, increasing preference for MIS procedures in ENT specialty, and growing healthcare outlay are boosting the industry.

To learn more about this report: https://bit.ly/42A58iL

Diagnostic devices had the largest share, of above 44%. This is because of the obtainability of numerous products, entrance of new players, rise in the ageing population, and surge in the occurrence of numerous ENT ailments. Furthermore, the new product launch will propel the industrial growth.

Hearing aids follow diagnostic devices. This is since manufacturers are further focused on introducing advanced hearing aids to consolidate their presence in the market. 

North America was the regional leader with around 33%, in the past. This has a lot to do with to the improving recompence scenario for ENT processes and the existence of the market stalwarts’ players in North America. Furthermore, the increasing consciousness about the benefits of ENT devices is a reason for the increased acceptance of these devices.

APAC will have the highest growth rate in the years to come, where the Peoples Republic and India are the main regional markets. The main driving forces are the existence of a high patient pool who have sinusitis, the surge in consciousness about these devices, and the increase in the ageing population in the region.

The increasing elderly population and the increasing incidence of hearing ailments will help the demand for ENT devices to boom further in the years to come.

Read More

Portable Ultrasound Devices Ruling the Roost, Why Is It So?

Before we understand about the portable version of ultrasound, let’s take a dive into the concept of ultrasound machines. Most of you must be familiar about what are ultrasound devices but let us discuss about them here in detail, for making the understanding clearer. When doctors or medical experts want to have a better look at what’s going on inside the patient’s body, they often use them for getting diagnostic imaging.

This imaging is done with the help of an ultrasound device. An ultrasound machine is also known as an ultrasonography machine, which takes pictures of internal organs from the topmost layer of the skin without any insertion with the help of high-frequency sound waves.  

A gel is applied on the skin in order to get the ultrasound waves transmitted from the transducer through the gel into the body. These images or scans are reflected on an attached computer screen. 

These images are used by medical experts for diagnosing problems with any tissue or the organ of the body. Ultrasounds are mostly performed for heart, stomach, liver, kidneys, uterus, unborn foetus, pancreas, etc. These images help the medical experts to understand the condition of any tissue or organ and make a more accurate diagnosis, on the basis of the same.

Portable Ultrasound Devices

As the name suggests, a portable ultrasound machine is a portable or smaller version of an ultrasound machine that almost has the same functions as the conventional device. However, these machines are not able to produce detailed imaging as the conventional counterpart, but they help in instant diagnosis. These mobile ultrasound systems could be carried here and there and work on batteries as well. 

Get the sample pages of this report: https://bit.ly/3n6qS5Q

Benefits of Portable Ultrasound Devices

Instant Diagnoses: Portable ultrasound devices give accurate and instant diagnoses as they can be done at the bedside of the patient. Full-size ultrasound machines are not that easy to be moved or transported. On the other hand, portable ultrasounds can be moved from one place to other.

Affordability: Conventional ultrasound devices are bulky and expensive. Whereas, portable devices are not just handy but also affordable. This helps hospitals provide individual device to the doctors and other medical practitioners.

Emergency Usage: The queue in front of the ultrasound room could be life threatening in some cases, when the patient is critical. Portable ultrasound machines eliminate the transporting challenge for emergency patients by providing imaging at the patient’s location.

Why ultrasound is preferred over other types of imaging

No Ionizing Radiation: One of the foremost benefits of ultrasound imaging are that it works on ultrasonic sound waves for developing images. Ultrasound techniques do not use radiation. So, there are almost no adverse patient responses as opposed to radiation exposure.

Non-Invasive Procedure- Another major benefit of ultrasound is that it does not require invasive procedures. 

Ultrasound imaging makes use of high-frequency sound waves to produce images of the internals of the body. With no first-hand risks, the portable ultrasound devices not just benefit the patients but also the doctors. Owing to all these benefits associated with portable ultrasound devices, the demand for the same will reach to a value of above $3,488 million by 2030.

Read More

Rising Prevalence of Chronic Diseases Boost Demand for Wearable Injectors

The wearable injectors industry contributes $6.95 billion in 2021, and it is projected to advance at a rate of 12.6% from 2021 to 2030, to generate $20.21 billion in 2030. It is ascribed to rising health hazard concerns, led by conventional injectors, coupled with growing demand for conventional and novel drug molecules.

In addition, the rising prevalence of chronic diseases, including cancer, diabetes, and cardiovascular diseases, and favorable reimbursement policies are projected to boost the demand for wearable injectors in the coming years.

To learn more about this report: https://bit.ly/3JKeXmS

Infusion therapy costs around $35 billion in the specialty drug industry. The subcutaneous injection is the most popular administration route in various therapeutic areas, including hemophilia, cancer, autoimmune disorders, and multiple sclerosis. It accounts for 50% of the expenditure on specialty medicine in the U.S.

The single-dose administration through IV infusion in the clinic or hospital costs around $1,000 to $10,000, while the homecare administration of the same dose costs 30% to 70% lesser.

The home usage of advanced medicine delivery devices, more specifically wearable injectors results in overall cost reduction, with an infusion of the medication by themselves, with no or minimal training.

In addition, these devices are economic compared to other controlled-delivery devices, as they are widely preferred options in laboratories, diagnostic centers, and clinics.

Moreover, the cheaper prices of these devices, compared to other controlled-delivery devices, resulted in their wide popularity in laboratories, clinics, and diagnostic centers.

Furthermore, biological drugs are large molecules, and more viscous compared to other drugs. They cause lesser pain during injection. The usage of the biological molecules with pharmacokinetics and subcutaneous back pressure boosts the usage of the biological molecules.

The slow administration of the drug is required for reducing patient discomfort and improving the drug's performance. For example, immunoglobulins are used for administering large volumes, and therefore, the preferred method is subcutaneous delivery. Immunoglobulins are administered in a specialized clinic or in a hospital through insertion sets or syringe pumps.

Wearable injectors are massively used compared to conventional drug delivery approaches, as they work efficiently in drug administration, at a controlled rate.

Presently, four subcutaneous immunoglobulins are commercially used in the U.S., with a tolerance flow rate ranging from 20 mL/h to 30 mL/h per site. There are various pipeline biological drugs in the R&D phase, with wide usage of oncology in the treatment, followed by autoimmune disorders and infectious diseases.

Wearable injectors provide support in reducing the overall healthcare cost, including drug administration and improvement in patients’ lives, thus fuelling the industry's growth.

The major players operating in the industry are; Medtronic plc, SteadyMed Ltd., Ypsomed Group, Unilife Corporation, Insulet Corporation, F.Hoffmann-La Roche Ltd., Johnson & Johnson, Becton, Dickinson, and Company, and West Pharmaceutical Services Inc.

Therefore, the rising demand for wearable injectors is led by the growing prevalence of chronic diseases.

Read More

Why does the Pharmaceutical Sector Need RTU/RTF Vails?

Vials marked as ready-to-fill (RTF) or ready-to-use (RTU) are provided in a state that allows for quick filling without additional processing. For this, the vials must be thoroughly cleaned to get rid of dirt and chemicals, depyrogenated to get rid of endotoxins, and then terminally sterilized. Frequently, the vials come with the proper caps and stoppers to shut the bottles after filling. Glass RTU/RTF vials come in a wide variety of sizes and characteristics.

Increased demand for injectable medications, rising healthcare costs, expanding pharmaceutical sector, and the need for pharmaceutical businesses to boost operational efficiency are driving the growth of the worldwide RTF/RTU vials market.

Get the sample pages of this report: https://bit.ly/3KA8I5T

Manufacture of Ready-to-Use (RTU) Glass Vials

The initial production of ready-to-use glass vials is the same as that of regular glass vials. After production, the vials undergo different treatments or are sent to a different facility for additional care.

Washing. Normally, this procedure is carried out with an automatic washer. Vials will be sprayed with pressured, heated, high-quality water by the washer both within and outside.

Depyrogenation. The goal of this procedure, which is carried out in a hot oven, is to purge the vials of endotoxins. In a typical cycle, the vials are heated for around 30 minutes at 250°C.

Sterilization towards the end. The vials are packed in a sterile barrier before being sterilized with moist heat or ethylene oxide in this procedure.

More Information Related to RTU Glass Vials

1. The vials must be safeguarded against microbiological contamination during the depyrogenation procedure and before the filling procedure because there is no terminal sterilizing before filling. The degree of sterility guaranteed of 106 reached with terminal sterilization cannot be matched by an inline method, not even with the finest precautions.

2. Investing much in infrastructure and equipment is necessary for an inline process. For businesses that fill a few vials, this might not be feasible.

3. Endotoxins and sub-visible particles must pass a number of batch tests during the manufacturing of vials before filling. These tests are finished before filling ready-to-use vials. A test failure with inline systems may result in the rejection of the entire batch.

Why Usage of Injectable Drugs Is Increasing

In the upcoming years, the market for injectable medication delivery is expected to grow rapidly as a consequence of the increase in diabetes and cancer cases. For autoimmune illnesses, oncological disorders, hormonal abnormalities, orphan diseases, and a variety of other conditions, drugs are injected into the body.

Patients who are unable to take medications orally, nasally, or through other methods that involve motor functions—such as if they are unconscious or comatose—benefit from injectables. Due to the fact that RTF/RTU vials are mostly used for injectable medications, the increasing demand for injectable pharmaceuticals is driving up the need for vials.

Pharmaceutical Companies Must Improve Their Operational Effectiveness

Pharmaceutical companies are putting their efforts into simplifying their business processes and focusing on their core strengths, such as manufacturing and processing. Due to the elimination of numerous procedures, including washing, dehydrogenating, and sterilizing the vials, they are now employing RTF/RTU vials.

These procedures reduce the overall operational effectiveness of a pharmaceutical company and are not core business practices. As a result, pharmaceutical companies now favor fill/finish technology and packaging that can ensure sterility without incurring high costs.

Read More

Transdermal Drug Delivery Systems Market Growing Owing to the Need to Deal with Pain

 Across the world, the lifestyle is becoming increasingly sedentary and fast paced. While sitting on a chair in offices all day leads to physical inactivity, the fast pace of life results in emotional stress. With lack of time, people’s dietary pattern gets affected, which leads to improper nutrition. All these factors, combined with tobacco and alcohol abuse, result in chronic diseases, such as diabetes, chronic obstructive pulmonary disease (COPD), cancer, and several cardiovascular diseases (CVD), the prevalence of all of which is rising. As per the World Health Organization, the number of diabetics rose to 422 million in 2014, from 108 million in 1980.

All these conditions require long-term medication, which is increasingly being delivered via the skin. Therefore, owing to the rising prevalence of chronic diseases, the transdermal drug delivery systems market is projected to grow from just over $30.0 billion in 2016, to more than $60.0 billion in size by 2023, at a CAGR of 9.8% during 2017–2023 (forecast period). Such devices are of two types — passive, which send the medication into the dermis simply via osmosis, and active, which use an external force, such as electricity, to accomplish the task. In 2016, the passive variants were more popular due to their easy application.

Across the globe, North America recorded the highest usage of such devices, due to the growing number of chronic disease patients and the increasing demand for drug delivery methods that are painless. During the forecast period, people in Asia-Pacific (APAC) are predicted to adopt such devices the most rapidly, as a result of the improving healthcare facilities, surging healthcare expenditure, high population, especially of the elderly, and increasing awareness on the technology. Within the region, the transdermal drug delivery systems market growth in India would be the fastest.

Thus, as the number of people suffering from painful conditions and diseases requiring medication increases, so would the use of devices that deliver medication through the skin, thereby making the process almost painless.

Read more: https://www.psmarketresearch.com/market-analysis/transdermal-drug-delivery-systems-market

Read More

Anti-Microbial Coating for Medical Devices Market Share and Forecast Report 2024

The global anti-microbial coating for medical devices market is growing, due to increasing number of hospitals and surgical centers, increasing number of free trade agreements, and technological advancement, such as nanocomposite coating technology, novel coating technology and parylene technology. The metallic coating segment is expected to dominate the market and non-metallic segment is expected to grow at the faster rate during the forecasted period. The silver coating is expected to dominate the metallic coating segment of the global market, and anticipated to grow with the fastest rate during the projected period. In addition, the polymer coating segment is expected to dominate the non-metallic coating segment of the market. On the basis of device type, the catheter segment dominates the market; however, the implantable devices segment is expected to grow with the fastest rate during the forecast period.

The massive unexplored market of the anti-microbial coating for medical devices industry in the developing economies is creating abundant growth opportunities for the market. Various medical devices comes in contact with complex bodily fluids, such as blood and urine; these devices need to be sanitized with anti-microbial coating. Antimicrobial coating is used in medical devices to reduce the risk of infection and demolish microorganisms from medical devices. These coatings should be bio-compatible, bio-stable and non-toxic for various medical devices.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=anti-microbial-coating-for-medical-devices-market

Asia-Pacific is expected to be the fastest growing region in the market, due to increasing number of hospitals, improving healthcare infrastructure, and increasing geriatric population in the region. In addition, the Asia-Pacific market of anti-microbial coating for medical devices is growing, due to increasing demand for high quality medical devices, increasing geriatric population, and increasing number of endoscopic surgeries in the emerging countries, such as India and China.

Anti-Microbial Coating for Medical Devices Market Segmentation

By Type of Material

• Metallic Coating
  • Silver coating
  • Copper coating
  • Others metallic coating
• Non-metallic Coating
  • Organic coating
  • Polymeric coating

By Device Type

• Implantable Devices
• Surgical Instruments
• Catheters
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World

Read More